{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:43:30Z","timestamp":1791233010311,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43556-y","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:15:30Z","timestamp":1773047730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Blood-based circulating microRNAs as diagnostic biomarkers in cutaneous melanoma: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"16","author":[{"given":"Hendra","family":"Pramono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L.","family":"Ekowati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel H.","family":"Pinandyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferbian M.","family":"Siswanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"43556_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"M Arnold","year":"2022","unstructured":"Arnold, M. et al. Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. JAMA dermatology. 158, 495\u2013503. https:\/\/doi.org\/10.1001\/jamadermatol.2022.0160 (2022).","journal-title":"JAMA dermatology"},{"key":"43556_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.14740\/wjon1349","volume":"12","author":"PP Naik","year":"2021","unstructured":"Naik, P. P. Cutaneous Malignant Melanoma: A Review of Early Diagnosis and Management. World J. Oncol. 12, 7\u201319. https:\/\/doi.org\/10.14740\/wjon1349 (2021).","journal-title":"World J. Oncol."},{"key":"43556_CR3","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","volume":"20","author":"LE Davis","year":"2019","unstructured":"Davis, L. E., Shalin, S. C. & Tackett, A. J. Current state of melanoma diagnosis and treatment. Cancer Biol. Ther. 20, 1366\u20131379. https:\/\/doi.org\/10.1080\/15384047.2019.1640032 (2019).","journal-title":"Cancer Biol. Ther."},{"key":"43556_CR4","doi-asserted-by":"publisher","first-page":"eRB5996","DOI":"10.31744\/einstein_journal\/2021RB5996","volume":"19","author":"AL Jorge","year":"2021","unstructured":"Jorge, A. L. et al. MicroRNAs: understanding their role in gene expression and cancer. Einstein (Sao Paulo Braz. 19, eRB5996. https:\/\/doi.org\/10.31744\/einstein_journal\/2021RB5996 (2021).","journal-title":"Einstein (Sao Paulo Braz"},{"key":"43556_CR5","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.3390\/ijms22126395","volume":"22","author":"S Strashilov","year":"2021","unstructured":"Strashilov, S. & Yordanov, A. Aetiology and Pathogenesis of Cutaneous Melanoma: Current Concepts and Advances. Int. J. Mol. Sci. 22, 6395. https:\/\/doi.org\/10.3390\/ijms22126395 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"43556_CR6","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.3390\/ijms21176183","volume":"21","author":"B Polini","year":"2020","unstructured":"Polini, B. et al. Tumor Suppressor Role of hsa-miR-193a-3p and \u2013\u20095p in Cutaneous Melanoma. Int. J. Mol. Sci. 21, 6183. https:\/\/doi.org\/10.3390\/ijms21176183 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"43556_CR7","doi-asserted-by":"publisher","first-page":"e0204387","DOI":"10.1371\/journal.pone.0204387","volume":"14","author":"I Datar","year":"2019","unstructured":"Datar, I. et al. Critical role of miR-10b in B-RafV600E dependent anchorage independent growth and invasion of melanoma cells. PLOS ONE. 14, e0204387. https:\/\/doi.org\/10.1371\/journal.pone.0204387 (2019).","journal-title":"PLOS ONE"},{"key":"43556_CR8","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2147\/OTT.S234276","volume":"13","author":"Y Yu","year":"2020","unstructured":"Yu, Y., Yu, F. & Sun, P. MicroRNA-1246 Promotes Melanoma Progression Through Targeting FOXA2. OncoTargets Ther. 13, 1245\u20131253. https:\/\/doi.org\/10.2147\/OTT.S234276 (2020).","journal-title":"OncoTargets Ther."},{"key":"43556_CR9","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3390\/cancers17111784","volume":"17","author":"M Manganelli","year":"2025","unstructured":"Manganelli, M. et al. Skin Photodamage and Melanomagenesis: A Comprehensive Review. Cancers 17, 1784. https:\/\/doi.org\/10.3390\/cancers17111784 (2025).","journal-title":"Cancers"},{"key":"43556_CR10","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.3390\/ijms23073996","volume":"23","author":"T Pozniak","year":"2022","unstructured":"Pozniak, T., Shcharbin, D. & Bryszewska, M. Circulating microRNAs in Medicine. Int. J. Mol. Sci. 23, 3996. https:\/\/doi.org\/10.3390\/ijms23073996 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"43556_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien, J., Hayder, H., Zayed, Y. & Peng, C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front. Endocrinol. 9, 402. https:\/\/doi.org\/10.3389\/fendo.2018.00402 (2018).","journal-title":"Front. Endocrinol."},{"key":"43556_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.suronc.2016.05.017","volume":"25","author":"N Latchana","year":"2016","unstructured":"Latchana, N., Ganju, A., Howard, J. H. & Carson, W. E. MicroRNA dysregulation in melanoma. Surg. Oncol. 25, 184\u2013189. https:\/\/doi.org\/10.1016\/j.suronc.2016.05.017 (2016).","journal-title":"Surg. Oncol."},{"key":"43556_CR13","doi-asserted-by":"publisher","first-page":"149186","DOI":"10.1016\/j.gene.2024.149186","volume":"939","author":"M Nobrega","year":"2025","unstructured":"Nobrega, M. et al. Comparative analysis of extracellular vesicles miRNAs (EV-miRNAs) and cell-free microRNAs (cf-miRNAs) reveals that EV-miRNAs are more promising as diagnostic and prognostic biomarkers for prostate cancer. Gene 939, 149186. https:\/\/doi.org\/10.1016\/j.gene.2024.149186 (2025).","journal-title":"Gene"},{"key":"43556_CR14","doi-asserted-by":"publisher","unstructured":"Endzelin Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients. BMC cancer. 17, 730. https:\/\/doi.org\/10.1186\/s12885-017-3737-z (2017).","DOI":"10.1186\/s12885-017-3737-z"},{"key":"43556_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/cancers15010080","volume":"15","author":"Q Ye","year":"2022","unstructured":"Ye, Q. et al. Exosome-Derived microRNA: Implications in Melanoma Progression, Diagnosis and Treatment. Cancers 15, 80. https:\/\/doi.org\/10.3390\/cancers15010080 (2022).","journal-title":"Cancers"},{"key":"43556_CR16","doi-asserted-by":"publisher","first-page":"1180799","DOI":"10.3389\/fmed.2023.1180799","volume":"10","author":"E De Martino","year":"2023","unstructured":"De Martino, E. et al. A group of three miRNAs can act as candidate circulating biomarkers in liquid biopsies from melanoma patients. Front. Med. 10, 1180799. https:\/\/doi.org\/10.3389\/fmed.2023.1180799 (2023).","journal-title":"Front. Med."},{"key":"43556_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2340\/00015555-2156","volume":"96","author":"V Armand-Labit","year":"2016","unstructured":"Armand-Labit, V. et al. Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma. Acta Derm Venereol. 96, 29\u201334. https:\/\/doi.org\/10.2340\/00015555-2156 (2016).","journal-title":"Acta Derm Venereol."},{"key":"43556_CR18","doi-asserted-by":"publisher","first-page":"101042831770164","DOI":"10.1177\/1010428317701646","volume":"39","author":"S Fogli","year":"2017","unstructured":"Fogli, S. et al. Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma. Tumor Biol. 39, 101042831770164. https:\/\/doi.org\/10.1177\/1010428317701646 (2017).","journal-title":"Tumor Biol."},{"key":"43556_CR19","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jid.2015.12.041","volume":"136","author":"S Guo","year":"2016","unstructured":"Guo, S. et al. Serum miR-16: A Potential Biomarker for Predicting Melanoma Prognosis. J. Investig Dermatol. 136, 985\u2013993. https:\/\/doi.org\/10.1016\/j.jid.2015.12.041 (2016).","journal-title":"J. Investig Dermatol."},{"key":"43556_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/cancers11010070","volume":"11","author":"C Sol\u00e9","year":"2019","unstructured":"Sol\u00e9, C. et al. The Circulating Transcriptome as a Source of Biomarkers for Melanoma. Cancers 11, 70. 10.3390 (2019).","journal-title":"Cancers"},{"key":"43556_CR21","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.12998\/wjcc.v7.i19.2930","volume":"7","author":"H Mo","year":"2019","unstructured":"Mo, H. et al. Expression and predictive value of miR-489 and miR-21 in melanoma metastasis. World J. Clin. Cases. 7, 2930\u20132941. https:\/\/doi.org\/10.12998\/wjcc.v7.i19.2930 (2019).","journal-title":"World J. Clin. Cases"},{"key":"43556_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/1471-2407-10-262","volume":"10","author":"P Leidinger","year":"2010","unstructured":"Leidinger, P. et al. High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer 10, 262. https:\/\/doi.org\/10.1186\/1471-2407-10-262 (2010).","journal-title":"BMC Cancer"},{"key":"43556_CR23","doi-asserted-by":"publisher","unstructured":"Stark, M. S. et al. The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis. EBioMedicine 2, 671\u2013680, (2015). https:\/\/doi.org\/10.1016\/j.ebiom.2015.05.011","DOI":"10.1016\/j.ebiom.2015.05.011"},{"key":"43556_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/bjd\/ljad137","volume":"189","author":"R Van Laar","year":"2023","unstructured":"Van Laar, R. et al. Validation of a microRNA liquid biopsy assay for diagnosis and risk stratification of invasive cutaneous melanoma. Br. J. Dermatol. 189, 292\u2013301. https:\/\/doi.org\/10.1093\/bjd\/ljad137 (2023).","journal-title":"Br. J. Dermatol."},{"key":"43556_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s12967-022-03668-1","volume":"20","author":"C Sabato","year":"2022","unstructured":"Sabato, C. et al. A novel microRNA signature for the detection of melanoma by liquid biopsy. J. Transl Med. 20, 469. https:\/\/doi.org\/10.1186\/s12967-022-03668-1 (2022).","journal-title":"J. Transl Med."},{"key":"43556_CR26","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.7150\/jca.18824","volume":"8","author":"M Bai","year":"2017","unstructured":"Bai, M. et al. Upregulation of Serum miR-10b Is Associated with Poor Prognosis in Patients with Melanoma. J. Cancer. 8, 2487\u20132491. https:\/\/doi.org\/10.7150\/jca.18824 (2017).","journal-title":"J. Cancer"},{"key":"43556_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/CMR.0000000000000450","volume":"28","author":"L Tengda","year":"2018","unstructured":"Tengda, L. et al. Serum exosomal microRNAs as potent circulating biomarkers for melanoma. Melanoma Res. 28, 295\u2013303. https:\/\/doi.org\/10.1097\/CMR.0000000000000450 (2018).","journal-title":"Melanoma Res."},{"key":"43556_CR28","doi-asserted-by":"publisher","unstructured":"Wang, K. et al. Comparing the MicroRNA spectrum between serum and plasma. PloS One 7, e41561, (2012). https:\/\/doi.org\/10.1371\/journal.pone.0041561","DOI":"10.1371\/journal.pone.0041561"},{"key":"43556_CR29","doi-asserted-by":"publisher","first-page":"e00376","DOI":"10.1016\/j.plabm.2024.e00376","volume":"39","author":"I Wakabayashi","year":"2024","unstructured":"Wakabayashi, I., Marumo, M., Ekawa, K. & Daimon, T. Differences in serum and plasma levels of microRNAs and their time-course changes after blood collection. Pract. Lab. Med. 39, e00376. https:\/\/doi.org\/10.1016\/j.plabm.2024.e00376 (2024).","journal-title":"Pract. Lab. Med."},{"key":"43556_CR30","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.4161\/cc.10.11.15777","volume":"10","author":"E Chan","year":"2011","unstructured":"Chan, E. et al. MicroRNA signatures differentiate melanoma subtypes. Cell. Cycle (Georgetown Tex). 10, 1845\u20131852. https:\/\/doi.org\/10.4161\/cc.10.11.15777 (2011).","journal-title":"Cell. Cycle (Georgetown Tex)"},{"key":"43556_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00428-012-1309-9","volume":"461","author":"LC Van Kempen","year":"2012","unstructured":"Van Kempen, L. C. et al. Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression. Virchows Arch. 461, 441\u2013448. https:\/\/doi.org\/10.1007\/s00428-012-1309-9 (2012).","journal-title":"Virchows Arch."},{"key":"43556_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jdermsci.2010.12.010","volume":"61","author":"H Kanemaru","year":"2011","unstructured":"Kanemaru, H. et al. The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. J. Dermatol. Sci. 61, 187\u2013193. https:\/\/doi.org\/10.1016\/j.jdermsci.2010.12.010 (2011).","journal-title":"J. Dermatol. Sci."},{"key":"43556_CR33","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.12659\/MSM.891327","volume":"20","author":"P Li","year":"2014","unstructured":"Li, P., He, Q., Luo, C. & Qian, L. Circulating miR-221 expression level and prognosis of cutaneous malignant melanoma. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 20, 2472\u20132477. https:\/\/doi.org\/10.12659\/MSM.891327 (2014).","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"43556_CR34","doi-asserted-by":"publisher","first-page":"948959","DOI":"10.3389\/fbioe.2022.948959","volume":"10","author":"D Xu","year":"2022","unstructured":"Xu, D. et al. . MicroRNAs in extracellular vesicles: Sorting mechanisms, diagnostic value, isolation, and detection technology. Front. Bioeng. Biotechnol. 10, 948959. https:\/\/doi.org\/10.3389\/fbioe.2022.948959 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"43556_CR35","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/CMR.0000000000000743","volume":"31","author":"LX Yang","year":"2021","unstructured":"Yang, L. X., Guo, H. B., Liu, S. Y., Feng, H. P. & Shi, J. ETS1 promoted cell growth, metastasis and epithe- lial\u2013mesenchymal transition process in melanoma by regulating miR-16-mediated SOX4 expression. Melanoma Res. 31, 298\u2013308. https:\/\/doi.org\/10.1097\/CMR.0000000000000743 (2021).","journal-title":"Melanoma Res."},{"key":"43556_CR36","doi-asserted-by":"crossref","unstructured":"Macaskill, P., Takwoingi, Y., Deeks, J. J. & Gatsonis, C. Chapter 9: Understanding meta-analysis. In Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy version 2.0 edn. (2023).","DOI":"10.1002\/9781119756194.ch9"},{"key":"43556_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ n71. https:\/\/doi.org\/10.1136\/bmj.n71 (2021).","journal-title":"BMJ n71"},{"key":"43556_CR38","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1158\/0008-5472.CAN-15-0287","volume":"75","author":"CP Bracken","year":"2015","unstructured":"Bracken, C. P., Khew-Goodall, Y. & Goodall, G. J. Network-Based Approaches to Understand the Roles of miR-200 and Other microRNAs in Cancer. Cancer Res. 75, 2594\u20132599. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0287 (2015).","journal-title":"Cancer Res."},{"key":"43556_CR39","doi-asserted-by":"publisher","first-page":"5874","DOI":"10.3390\/cancers13235874","volume":"13","author":"I Cavallari","year":"2021","unstructured":"Cavallari, I. et al. The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers. Cancers 13, 5874. https:\/\/doi.org\/10.3390\/cancers13235874 (2021).","journal-title":"Cancers"},{"key":"43556_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/13880209.2017.1418391","volume":"56","author":"YG Peng","year":"2018","unstructured":"Peng, Y. G. & Zhang, L. Baohuoside-I suppresses cell proliferation and migration by up-regulating miR-144 in melanoma. Pharm. Biol. 56, 43\u201350. https:\/\/doi.org\/10.1080\/13880209.2017.1418391 (2018).","journal-title":"Pharm. Biol."},{"key":"43556_CR41","doi-asserted-by":"publisher","unstructured":"H\u00e4m\u00e4l\u00e4inen, M. et al. NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs. Oxidative Medicine Cell. Longev.\u00a02019, 1\u201315, https:\/\/doi.org\/10.1155\/2019\/2647068 (2019).","DOI":"10.1155\/2019\/2647068"},{"key":"43556_CR42","doi-asserted-by":"publisher","unstructured":"Felicetti, F., Errico, M. C., Segnalini, P., Mattia, G. & Car\u00e8, A. (X) MicroRNA-221 and \u2013\u2009222 pathway controls melanoma progression. Expert. Rev. Anticancer. Ther. 8, 1759\u20131765, (2008). https:\/\/doi.org\/10.1586\/14737140.8.11.1759","DOI":"10.1586\/14737140.8.11.1759"},{"key":"43556_CR43","doi-asserted-by":"publisher","first-page":"22262","DOI":"10.18632\/oncotarget.14763","volume":"8","author":"L Fattore","year":"2017","unstructured":"Fattore, L. et al. MicroRNAs in melanoma development and resistance to target therapy. Oncotarget 8, 22262\u201322278. https:\/\/doi.org\/10.18632\/oncotarget.14763 (2017).","journal-title":"Oncotarget"},{"key":"43556_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12920-015-0156-3","volume":"8","author":"I Venza","year":"2015","unstructured":"Venza, I. et al. IL-10R expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma. BMC Med. Genomics 8, 81. https:\/\/doi.org\/10.1186\/s12920-015-0156-3 (2015).","journal-title":"BMC Med. Genomics"},{"key":"43556_CR45","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.3892\/ol.2017.5699","volume":"13","author":"J He","year":"2017","unstructured":"He, J. et al. miR-185 enhances the inhibition of proliferation and migration induced by ionizing radiation in melanoma. Oncol. Lett. 13, 2442\u20132448. https:\/\/doi.org\/10.3892\/ol.2017.5699 (2017).","journal-title":"Oncol. Lett."},{"key":"43556_CR46","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.3892\/mmr.2016.5433","volume":"14","author":"J Zhou","year":"2016","unstructured":"Zhou, J., Jiang, J., Wang, S. & Xia, X. Oncogenic role of microRNA-20a in human uveal melanoma. Mol. Med. Rep. 14, 1560\u20131566. https:\/\/doi.org\/10.3892\/mmr.2016.5433 (2016).","journal-title":"Mol. Med. Rep."},{"key":"43556_CR47","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/cr.2008.45","volume":"18","author":"J Schultz","year":"2008","unstructured":"Schultz, J., Lorenz, P., Gross, G., Ibrahim, S. & Kunz, M. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell. Res. 18, 549\u2013557. https:\/\/doi.org\/10.1038\/cr.2008.45 (2008).","journal-title":"Cell. Res."},{"key":"43556_CR48","doi-asserted-by":"publisher","first-page":"608987","DOI":"10.3389\/fonc.2021.608987","volume":"11","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard, S., Gholipour, M. & Taheri, M. MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets. Front. Oncol. 11, 608987. https:\/\/doi.org\/10.3389\/fonc.2021.608987 (2021).","journal-title":"Front. Oncol."},{"key":"43556_CR49","doi-asserted-by":"publisher","first-page":"375","DOI":"10.7150\/jca.21044","volume":"9","author":"Y He","year":"2018","unstructured":"He, Y. et al. miR-149 in Human Cancer: A Systemic Review. J. Cancer. 9, 375\u2013388. https:\/\/doi.org\/10.7150\/jca.21044 (2018).","journal-title":"J. Cancer"},{"key":"43556_CR50","first-page":"83","volume":"10","author":"PM Howell","year":"2010","unstructured":"Howell, P. M., Li, X., Riker, A. I. & Xi, Y. MicroRNA in Melanoma. Ochsner J. 10, 83\u201392 (2010).","journal-title":"Ochsner J."},{"key":"43556_CR51","doi-asserted-by":"publisher","unstructured":"Pane, A. A. et al. MicroRNAs affecting the susceptibility of melanoma cells to CD8+ T cell-mediated cytolysis. Clin. Transl. Medicine 13, e1186, (2023). https:\/\/doi.org\/10.1002\/ctm2.1186","DOI":"10.1002\/ctm2.1186"},{"key":"43556_CR52","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3233\/CBM-240137","volume":"41","author":"Y Deng","year":"2024","unstructured":"Deng, Y., Patel, N., Ding, S. & Zhang, H. Mechanism study of serum extracellular nano-vesicles miR-412-3p targeting regulation of TEAD1 in promoting malignant biological behavior of sub-centimeter lung nodules. Cancer Biomarkers: Sect. Dis. Markers. 41, 69\u201382. https:\/\/doi.org\/10.3233\/CBM-240137 (2024).","journal-title":"Cancer Biomarkers: Sect. Dis. Markers"},{"key":"43556_CR53","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s12032-016-0804-2","volume":"33","author":"Y Wei","year":"2016","unstructured":"Wei, Y. et al. LncRNA UCA1-miR-507-FOXM1 axis is involved in cell proliferation, invasion and G0\/G1 cell cycle arrest in melanoma. Med. Oncol. 33, 88. https:\/\/doi.org\/10.1007\/s12032-016-0804-2 (2016).","journal-title":"Med. Oncol."},{"key":"43556_CR54","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4149\/neo_2019_190414N328","volume":"67","author":"J Shi","year":"2020","unstructured":"Shi, J. et al. MiR-1203 is involved in hepatocellular carcinoma metastases and indicates a poor prognosis. Neoplasma 67, 267\u2013276. https:\/\/doi.org\/10.4149\/neo_2019_190414N328 (2020).","journal-title":"Neoplasma"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43556-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43556-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43556-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:56:37Z","timestamp":1776383797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43556-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43556"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43556-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"2 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12687"}}